Home | Sitemap | Submit Content | Contact Us   
imageHome : Latest News : Eisai's 'Aa3' issuer rating on review for downgrade on MGI Pharma buy ...

Eisai's 'Aa3' issuer rating on review for downgrade on MGI Pharma buy ...

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service62 times read : Adjust font size: Decrease font Enlarge font
image

CNBC - MUMBAI (Thomson Financial) - Moody's Investors Service said it placed Eisai Co Ltd's 'Aa3' issuer rating under review for possible downgrade after the Japanese pharma company said it reached a definitive merger agreement with US biopharma company MGI ...

Read this article...



Post your comment comment Comments (0 posted)

More News

copyright